{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Medorubicin",
  "nciThesaurus": {
    "casRegistry": "64314-52-9",
    "chebiId": "",
    "chemicalFormula": "C26H27NO10",
    "definition": "A demethoxy derivative of doxorubicin with antineoplastic activity.",
    "fdaUniiCode": "NU158DGH9E",
    "identifier": "C87599",
    "preferredName": "Medorubicin",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C1594"
    ],
    "synonyms": [
      "(1S,3S)-3-Glycoloyl-1,2,3,4,6,11-Hexahydro-3,5,12-Trihydroxy-6,11-Dioxo-1-Naphthacenyl 3-Amino-2,3,6-Trideoxy-Alpha-L-Lyxo-Hexopyranoside",
      "4-Demethoxydoxorubicin",
      "MEDORUBICIN",
      "Medorubicin"
    ]
  }
}